Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Bill would let New Hampshire therapeutic dispensaries use hemp-derived, nonintoxicating cannabinoids
Summary
Supporters told the House Judiciary Committee that House Bill 51 would allow New Hampshire alternative treatment centers (ATCs) to buy federally legal hemp-derived, nonintoxicating cannabinoids such as CBD for use in therapeutic cannabis products, while opponents warned of legal uncertainty around sourcing and interstate transport.
House Bill 51 would permit alternative treatment centers in New Hampshire to obtain hemp-derived, nonintoxicating cannabinoids such as CBD from federally legal hemp producers and use them in products sold to registered therapeutic cannabis patients.
The bill’s sponsor, Representative Wendy Thomas (representing Merrimack), told the committee that HB 51 “would allow ATCs, which are alternative treatment centers, to buy non intoxicating cannabinoids from federally legal hemp producers and utilize them in some of the products that they use for patients in New Hampshire.” She emphasized the bill would not apply to hemp-derived THC products, “which are not legal in New Hampshire.”
Why it matters: Supporters say the change would reduce costs and expand patients’ access to CBD and other nonintoxicating cannabinoids that some patients prefer for conditions such as chronic pain, anxiety and seizures. The bill would also require DHHS oversight and testing: supporters stressed products would be tested for…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
